Catalysts for $PFE

PAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approval

HEPARIN SODIUM — FDA approval

HYMPAVZI (MARSTACIMAB-HNCQ) — FDA approval

METHYLPREDNISOLONE — FDA approval

METHYLPREDNISOLONE — FDA approval

XELJANZ (TOFACITINIB CITRATE) — FDA approval

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

PAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approval

ELREXFIO (ELRANATAMAB) — FDA approval

CLEOCIN HYDROCHLORIDE (CLINDAMYCIN HYDROCHLORIDE) — FDA approval

DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) — FDA approval

DEPO-SUBQ PROVERA 104 (MEDROXYPROGESTERONE ACETATE) — FDA approval

ELELYSO (TALIGLUCERASE ALFA) — FDA approval

DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval

MEDROL (METHYLPREDNISOLONE) — FDA approval

XELJANZ (TOFACITINIB CITRATE) — FDA approval

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

UNASYN (AMPICILLIN SODIUM) — FDA approval

ABRILADA (ADALIMUMAB-AFZB) — FDA approval

ESTRING (ESTRADIOL) — FDA approval

IXIFI (INFLIXIMAB-QBTX) — FDA approval

DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval

MEDROL (METHYLPREDNISOLONE) — FDA approval

ELREXFIO (ELRANATAMAB) — FDA approval

IDARUBICIN HYDROCHLORIDE — FDA approval

ABRILADA (ADALIMUMAB-AFZB) — FDA approval

ABRILADA (ADALIMUMAB-AFZB) — FDA approval

ELREXFIO (ELRANATAMAB) — FDA approval

ABRILADA (ADALIMUMAB-AFZB) — FDA approval

PAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approval